- 专利标题： COMPOSITIONS AND METHODS FOR NASAL ADMINISTRATION OF DRUGS TO BRAIN AND FOR SYSTEMIC EFFECT
-
申请号： US16814163申请日： 2020-03-10
-
公开(公告)号： US20200268662A1公开(公告)日： 2020-08-27
- 发明人: Elka TOUITOU , Hiba NATSHEH
- 申请人： YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD
- 主分类号： A61K9/107
- IPC分类号： A61K9/107 ; A61K38/28 ; A61K9/00 ; A61K47/24 ; A61K47/10 ; A61K47/02 ; A61K38/18 ; A61K38/095 ; A61K31/135 ; A61K31/4196 ; A61K31/047 ; A61K31/05 ; A61K31/551 ; A61K31/485 ; A61K31/192 ; A61K38/12 ; A61K31/165 ; A61K31/426 ; A61P25/16
摘要：
The invention relates to a nasally administrable composition comprising at least one active substance in magnesium-containing vesicular carrier, said carrier comprising glycol, phospholipids, water and at least one magnesium source. Methods for nasal administration of the composition, for example, for pain relief, are also provided.
信息查询
